July 2024 Update

Welcome to the July 2024 edition of the Seaside Ventures newsletter! We hope everyone is having a wonderful summer. This month, we're excited to share the latest news featuring our portfolio companies, details about an upcoming Seaside Hike in Los Angeles, and the latest insights from our Wellness Wednesdays series.

—Ryan Roddy, Harrison Valner, & The Seaside Team

Portfolio in the News

Samphire Neuroscience

Samphire's neurotechnology?headband for period pain and PMS has been featured in the Daily Mail. Their flagship product?offers a new way to manage menstrual discomfort.

Discover how it works and its benefits here.

Plan A

Plan A's male birth control solution is making waves as a new option in reproductive health. Spectrum News covered this innovative approach, exploring its potential impact.

Learn more about this development here.

ZBiotics

ZBiotics' co-founder and microbiologist breaks down myths and misconceptions about GMO probiotics in an insightful NutraCast interview.

Get the facts about their work here.

Thought Leadership and Internal Insights?

Bioprinting Organs: The Future of Transplant Medicine

Ryan Roddy explores the potential of bioprinting to revolutionize organ transplants, offering hope for countless patients in need.

Read the full article here.

Seaside Hike in Los Angeles

We are excited to announce our upcoming Seaside Hike in Los Angeles on August 23. As we've seen before, the hike represents a great opportunity for founders and investors to connect in a beautiful outdoor setting. Mark your calendars and send us an email if you'd like to attend!

Co-Investment Opportunity

We have an exciting opportunity in the sleep technology space for a co-investment. If you are interested in learning more, please reach out to us directly.

Thank you for reading the Seaside Ventures July 2024 Newsletter. We appreciate your continued support and look forward to keeping you updated on our journey in our next edition. ?

All the best,

The Seaside Ventures Team